Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology

Why is Gadolinium Contrast Used for Pituitary MRIs?

At a Glance

Gadolinium contrast is an IV dye used during a pituitary MRI to clearly distinguish a tumor from healthy tissue. Because tumors absorb the dye at a different rate than healthy glands, the contrast creates a precise visual map that is critical for safely removing the tumor during surgery.

In this answer

3 sections

01

How the Scan Works

02

Why This Mapping is Critical for Surgery

03

Safety, Brain Retention, and Next Steps

When you have a magnetic resonance imaging (MRI) scan for acromegaly, you will likely be given an intravenous (IV) dye called gadolinium contrast. This contrast agent acts like a medical highlighter that helps your doctors distinguish the pituitary tumor (called an adenoma) from your normal, healthy pituitary tissue. Because the healthy gland and the tumor absorb the dye at different speeds, the contrast creates a clear map of exactly where the tumor begins and ends [1][2].

How the Scan Works

During the MRI, you will initially go into the scanner without any dye. Partway through the procedure, the technologist will briefly slide you out of the machine to inject the gadolinium contrast into your IV, and then slide you back in for the remaining pictures.

During the injection, it is common to experience a transient “cold rush” or cooling sensation spreading from the IV site as the room-temperature fluid enters your bloodstream [3]. You might also notice a temporary metallic taste in your mouth [3]. These are normal physical reactions and usually pass within a few moments.

Once the dye is injected, the normal pituitary gland—which has a very rich blood supply—absorbs the contrast very quickly. Pituitary adenomas typically absorb the contrast more slowly [1]. In a technique known as dynamic contrast-enhanced imaging, the scanner takes pictures right as the dye flows in. The healthy pituitary tissue will “light up” brightly, while the tumor will temporarily appear darker [2][4]. This stark visual difference makes even very small tumors clearly visible to the radiologist.

Why This Mapping is Critical for Surgery

This precise mapping is essential for your neurosurgeon when planning your operation [4]. The primary goal of surgery for acromegaly is to achieve biochemical remission—meaning the tumor is completely removed and your growth hormone and Insulin-like Growth Factor 1 (IGF-1) levels return to normal [5][6]. To do this safely and effectively, the surgeon relies on the contrast-enhanced MRI to:

  • Protect healthy tissue: By clearly seeing the boundary between the adenoma and the rest of the gland, the surgeon can remove the tumor while preserving the healthy tissue needed for normal hormone function [4].
  • Navigate critical structures: The pituitary gland sits very close to important structures, including the cavernous sinus (a major space containing nerves and veins) and the internal carotid artery (a main blood vessel supplying the brain). Gadolinium contrast shows whether the tumor has touched or invaded these areas, providing a clear roadmap for your surgeon to safely navigate around these important structures [4][7]. (It is important to note that while MRI shows visible spread, microscopic invasion into surrounding tissues may only be discovered during the surgery itself [8][5].)

Safety, Brain Retention, and Next Steps

It is completely normal to feel anxious about receiving IV contrast dye. For the vast majority of patients, gadolinium-based contrast agents are safe, well-tolerated, and severe allergic reactions are very rare [9][10].

You may have read concerning information online about gadolinium staying in the brain. While it is true that trace amounts of older “linear” contrast agents could remain in brain tissues over time, modern imaging centers primarily use “macrocyclic” agents, which are chemically highly stable and significantly reduce this risk [11][12]. Most importantly, extensive clinical research has found no evidence that these trace amounts cause any neurological harm or adverse health effects [13][14].

Gadolinium is filtered out of your body by your kidneys [15]. Before the scan, your medical team will typically check your kidney function with a standard blood test to ensure your kidneys are healthy enough to clear the dye. If you have severe kidney disease, your doctor will discuss alternative options or specific safety protocols [16][17].

After your scan is complete, you will generally be advised to drink plenty of water throughout the rest of the day. Extra hydration helps your kidneys efficiently flush the contrast from your system, and the vast majority of the dye is typically eliminated within 24 hours [18][15].

Common questions in this guide

Why do I need contrast dye for a pituitary MRI?
Contrast dye helps your doctors clearly distinguish a pituitary tumor from healthy, normal tissue. The tumor and the healthy gland absorb the dye at different speeds, creating a precise visual map that is essential for a neurosurgeon planning your operation.
Is it normal to feel cold or taste metal during an MRI contrast injection?
Yes, it is very common to experience a temporary cold rush from the IV site or a metallic taste in your mouth during the injection. These are normal physical reactions to the fluid entering your bloodstream and usually pass within a few moments.
Is gadolinium contrast safe to use?
For the vast majority of patients, modern gadolinium contrast agents are safe and well-tolerated. Severe allergic reactions are rare. While trace amounts can remain in the body, clinical research shows no evidence that this causes neurological harm.
How does the contrast dye leave my body after the MRI?
Gadolinium is naturally filtered out of your bloodstream by your kidneys. Drinking plenty of water after your scan helps your kidneys efficiently flush the contrast from your system, and the vast majority of the dye is eliminated within 24 hours.
Why do I need a blood test before getting MRI contrast?
Your medical team will typically check your kidney function with a standard blood test before the scan. This ensures your kidneys are healthy enough to clear the dye. If you have severe kidney disease, your doctor will discuss alternative options or safety protocols.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific type of gadolinium (such as a macrocyclic agent) are you using for my MRI?
  2. 2.Can we discuss my recent kidney panel results to ensure it is safe for me to receive the contrast dye?
  3. 3.Has the tumor visibly invaded the cavernous sinus or touched the internal carotid artery on the MRI, and how does that affect my surgical plan?
  4. 4.Based on the tumor's boundaries shown by the contrast, how much of my healthy pituitary gland do you expect to preserve?
  5. 5.What are my chances of achieving complete biochemical remission (normalizing my growth hormone and IGF-1 levels) through surgery alone?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Will My Face and Hands Go Back to Normal After Acromegaly?How Does Acromegaly Affect Fertility and Pregnancy?Does Acromegaly Cause Severe Headaches? Causes & ReliefDoes Acromegaly Cause Jaw Changes and Malocclusion?Does Acromegaly Cause Joint Pain? Is It Reversible?Does Acromegaly Cause Voice Changes & Vocal Thickening?How Are Acromegaly Medications Administered?How Is Transsphenoidal Surgery for Acromegaly Performed?Is Acromegalic Cardiomyopathy Reversible?Is Acromegaly Hereditary? Genetic Causes ExplainedAcromegaly and Anesthesia: What Are the Airway Risks?What Are the Second-Line Treatments for Acromegaly?What Are the Side Effects of Acromegaly Radiation?What does the Knosp grade mean on a pituitary MRI?GH vs IGF-1 in Acromegaly: What is the Difference?What Is the Life Expectancy for Acromegaly Patients?Why Do Acromegaly Patients Need Frequent Colonoscopies?Why Monitor IGF-1 Instead of Growth Hormone on PegvisomantWhy is an Oral Glucose Tolerance Test Used for Acromegaly?

References

References (18)
  1. 1

    Use of DCE-MRI in arthritis in the appendicular skeleton: a narrative review.

    Boesen M, Iakimov A, Shakoor D, et al.

    Skeletal radiology 2025; (54(11)):2457-2479 doi:10.1007/s00256-025-04966-7.

    PMID: 40495074
  2. 2

    [Diagnose pituitary adenoma using dynamic enhanced MRI: a quantitative approach].

    Zheng W, Zhai J, Chen Y

    Zhonghua yi xue za zhi 2015; (95(23)):1837-41.

    PMID: 26712402
  3. 3

    Gadolinium-based contrast agents: why nephrologists need to be concerned.

    Leyba K, Wagner B

    Current opinion in nephrology and hypertension 2019; (28(2)):154-162 doi:10.1097/MNH.0000000000000475.

    PMID: 30531473
  4. 4

    Usefulness of pituitary high-resolution 3D MRI with deep-learning-based reconstruction for perioperative evaluation of pituitary adenomas.

    Ishimoto Y, Ide S, Watanabe K, et al.

    Neuroradiology 2024; (66(6)):937-945 doi:10.1007/s00234-024-03315-0.

    PMID: 38374411
  5. 5

    Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes.

    Mohyeldin A, Katznelson LJ, Hoffman AR, et al.

    Scientific reports 2022; (12(1)):9919 doi:10.1038/s41598-022-12980-1.

    PMID: 35705579
  6. 6

    Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients.

    Guo X, Zhang R, Zhang D, et al.

    Journal of neurosurgery 2022; (137(3)):618-628 doi:10.3171/2021.11.JNS212137.

    PMID: 35171834
  7. 7

    Invasive ACTH-secreting pituitary macroadenoma in remission after transsphenoidal resection: A case report and literature review.

    Zhuang Z, Liu X, Bao X, et al.

    Medicine 2018; (97(46)):e13148 doi:10.1097/MD.0000000000013148.

    PMID: 30431585
  8. 8

    Tumor characteristics and clinical outcomes in 113 patients with acromegaly: exploratory analysis of the role of histologic invasion of adjacent tissues.

    Eaton JC, Swaminathan S, El-Ghazali FM, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026; (143()):111771 doi:10.1016/j.jocn.2025.111771.

    PMID: 41317589
  9. 9

    Acute adverse reactions after multiple initially well-tolerated gadolinium-based contrast-enhanced abdomen MRIs in pediatric patients.

    Hojreh A, Mulabdic A, Heilos A, et al.

    PloS one 2024; (19(12)):e0313495 doi:10.1371/journal.pone.0313495.

    PMID: 39625932
  10. 10

    Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients.

    Ahn YH, Kang DY, Park SB, et al.

    Radiology 2022; (303(2)):329-336 doi:10.1148/radiol.210545.

    PMID: 35191737
  11. 11

    Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward.

    van der Molen AJ, Quattrocchi CC, Mallio CA, et al.

    European radiology 2024; (34(1)):600-611 doi:10.1007/s00330-023-10281-3.

    PMID: 37804341
  12. 12

    Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.

    Barisano G, Bigjahan B, Metting S, et al.

    AJNR. American journal of neuroradiology 2019; (40(8)):1274-1281 doi:10.3174/ajnr.A6148.

    PMID: 31345942
  13. 13

    A Review of the Current Evidence on Gadolinium Deposition in the Brain.

    Pullicino R, Radon M, Biswas S, et al.

    Clinical neuroradiology 2018; (28(2)):159-169 doi:10.1007/s00062-018-0678-0.

    PMID: 29523896
  14. 14

    Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.

    Ayers-Ringler J, McDonald JS, Connors MA, et al.

    Radiology 2022; (302(3)):676-683 doi:10.1148/radiol.210559.

    PMID: 34931861
  15. 15

    [Pharmacokinetics of gadolinium-based contrast agents].

    Czock D

    Der Radiologe 2019; (59(5)):408-412 doi:10.1007/s00117-019-0496-7.

    PMID: 30725143
  16. 16

    Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.

    Schieda N, Blaichman JI, Costa AF, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2018; (69(2)):136-150 doi:10.1016/j.carj.2017.11.002.

    PMID: 29706252
  17. 17

    Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease: Consensus statements from nephrologists, cardiologists, and radiologists at National Taiwan University Hospital.

    Wang KC, Lin LC, Pan SY, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2026; (125(3)):261-267 doi:10.1016/j.jfma.2025.01.019.

    PMID: 39870554
  18. 18

    Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.

    Takahashi EA, Kallmes DF, Mara KC, et al.

    Diagnostic and interventional radiology (Ankara, Turkey) 2018; (24(6)):378-384 doi:10.5152/dir.2018.18172.

    PMID: 30406762

This page explains the use of gadolinium contrast for educational purposes. Always consult your endocrinologist, neurosurgeon, or radiologist regarding your specific imaging and treatment plan.

Get notified when new evidence is published on Acromegaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.